507 related articles for article (PubMed ID: 33141814)
1. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
2. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
Zhu F; Cao Y; Xu S; Zhou M
J Med Virol; 2020 Jun; 92(6):529-530. PubMed ID: 32160316
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
4. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
[No Abstract] [Full Text] [Related]
6. [Not Available].
Balavoine JF
Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
[No Abstract] [Full Text] [Related]
7. HIV and Human Coronavirus Coinfections: A Historical Perspective.
Makoti P; Fielding BC
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858801
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
[TBL] [Abstract][Full Text] [Related]
9. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
10. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
11. COVID-19 serologic testing: FAQs and caveats.
Kadkhoda K
Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
[No Abstract] [Full Text] [Related]
12. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
Castel AD; Wilbourn B; Magnus M; Greenberg AE
AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
[TBL] [Abstract][Full Text] [Related]
14. Type 1 interferons as a potential treatment against COVID-19.
Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
[TBL] [Abstract][Full Text] [Related]
15. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
16. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
Krishan K; Kanchan T
Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Rescue by transcriptional inhibition.
Shilatifard A
Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
[No Abstract] [Full Text] [Related]
18. Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2.
Song M; Li ZL; Zhou YJ; Tian G; Ye T; Zeng ZR; Deng J; Wan H; Li Q; Liu JB
J Zhejiang Univ Sci B; 2020 Sept.; 21(9):749-751. PubMed ID: 32893532
[TBL] [Abstract][Full Text] [Related]
19. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
20. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
Calligari P; Bobone S; Ricci G; Bocedi A
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
